Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FOXC1 |
| Upstream (Parents) |
|---|
| (<<) FOXA1 → FOXC1 |
| (<<) SPDEF → FOXC1 |
| (<<) TAF4B → FOXC1 |
| (<<) L3MBTL4 → FOXC1 |
| Downstream (Children) |
|---|
| FOXC1 → TFAP2B (>>) |
| FOXC1 → ELF5 (>>) |
| FOXC1 → IRX1 (>>) |
| FOXC1 → EN1 (>>) |
| FOXC1 → ZIC1 (>>) |
| FOXC1 → SOX8 (>>) |
| FOXC1 → SOX10 (>>) |
| FOXC1 → CDKN2A (>>) |
| FOXC1 → ANKRD30A (>>) |
| FOXC1 → FOXQ1 (>>) |
| FOXC1 → TFCP2L1 (>>) |
| FOXC1 → SOX6 (>>) |
| FOXC1 → GATA3 (>>) |
| FOXC1 → FOXD1 (>>) |
| FOXC1 → HOXC10 (>>) |
| FOXC1 → TRIM29 (>>) |
| FOXC1 → KLF5 (>>) |
| FOXC1 → AR (>>) |
| FOXC1 → HOXB3 (>>) |
| FOXC1 → NFIB (>>) |
| FOXC1 → SIX2 (>>) |
| FOXC1 → SOX9 (>>) |
| FOXC1 → NFIX (>>) |
| FOXC1 → ARNTL2 (>>) |
| FOXC1 → CREB3L4 (>>) |
| FOXC1 → RUNX3 (>>) |
| FOXC1 → MYC (>>) |
| FOXC1 → PAX7 (>>) |
| FOXC1 → MSX2 (>>) |
| FOXC1 → XBP1 (>>) |
| FOXC1 → RORC (>>) |
| FOXC1 → TCF7L1 (>>) |
| FOXC1 → HOXB2 (>>) |
| FOXC1 → ZNF91 (>>) |
| FOXC1 → ARX (>>) |
| FOXC1 → CREB3L1 (>>) |
| FOXC1 → LASS6 (>>) |
| FOXC1 → HR (>>) |
| FOXC1 → ZNF93 (>>) |
| FOXC1 → SATB1 (>>) |
| FOXC1 → SREBF1 (>>) |
| FOXC1 → NFYA (>>) |
| FOXC1 → RARA (>>) |
| FOXC1 → MEIS1 (>>) |
| FOXC1 → GATA2 (>>) |
| FOXC1 → TGIF2 (>>) |
| FOXC1 → ZSCAN18 (>>) |
| FOXC1 → PPARA (>>) |
| FOXC1 → TCF7L2 (>>) |
| FOXC1 → E2F3 (>>) |
| FOXC1 → ATF7 (>>) |
| FOXC1 → ZNF232 (>>) |
| FOXC1 → NOTCH1 (>>) |
| FOXC1 → HOXD1 (>>) |
| FOXC1 → THRA (>>) |
| FOXC1 → SUPT6H (>>) |
